Orchestra Bio
IPOManage the business of science
Public · San Francisco · $70.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Business Model
- B2B
- Website
- orchestra.bio
- Total Funding
- $70.0M
- Last Round
- $70.0M Corporate RoundJul 2025
- Rounds
- 1
- Type
- Public
About
Orchestra is an intelligent management platform for R&D organizations, helping biotech and pharmaceutical companies manage the business of science. The platform provides tools for R&D planning, program management, portfolio prioritization, and operational oversight, enabling teams to align scientific programs with strategic goals and track progress across complex multi-stage pipelines.
Summary
Orchestra Bio is a Healthcare company based in San Francisco. It has raised $70.0M in total across 1 round, most recently a $70.0M Corporate Round round in Jul 2025. Investors include Medtronic and Ligand Pharmaceuticals.
Tech & App Stack
11 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Hyland provides content services and intelligent automation solutions for enterprises.
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...